4.2 Article

Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome

Journal

NEUROPSYCHOLOGY
Volume 22, Issue 1, Pages 48-60

Publisher

AMER PSYCHOLOGICAL ASSOC
DOI: 10.1037/0894-4105.22.1.48

Keywords

fragile X; premutation; cognition; trinucieotide repeats; executive cognitive function

Funding

  1. NIMH NIH HHS [R01 MH078041] Funding Source: Medline
  2. NINDS NIH HHS [NS044299, R01 NS044299] Funding Source: Medline
  3. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078041] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044299] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Fragile X-associated tremor/ataxia syndrome (FXTAS) develops in a subset of fragile X premutation carriers and involves gait ataxia, action tremor. Parkinsonism, peripheral neuropathy, autonomic disorders, and cognitive impairment. The study was designed to define the nature of cognitive deficits affecting male premutation carriers with and without FXTAS. A sample of 109 men underwent motor, cognitive, genetic, and neurologic testing. as well as brain magnetic resonance imaging. Subjects were classified into 3 groups: (a) asymptomatic premutation carriers, (b) premutation carriers with FXTAS, and (c) normal controls. Men with FXTAS performed worse than controls on mental status, intelligence, executive cognitive functioning (ECF). working memory, remote recall of information, declarative learning and memory, information processing speed, and temporal sequencing, as well as I measure of visuospatial functioning. Language and verbal comprehension were spared. Asymptomatic carriers performed worse than controls on ECF and declarative learning and Memory. This comprehensive examination of cognitive impairment in male premutation carriers suggests that FXTAS involves substantial executive impairment and diffuse deficits in other cognitive functions. Longitudinal research currently underway will provide insight into the progression of the disorder.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available